 |
| | Speaker:
Prof. Peter Ebeling
Moderator:
Teréza Hough | Date: 24 November 2026
Time: 16:00 – 17.00 (CET)
Central European Time (UTC +1) |
|
| | Managing very high fracture risk patients within FLS settings | | |
|
| |
Osteoporosis care has evolved remarkably over the past 50 years, yet substantial opportunities for fracture prevention continue to be missed. Earlier identification and effective management of individuals at increased fracture risk remain essential to reducing the burden of fragility fractures. Ensuring that patients are consistently assessed and managed in line with evidence-based recommendations remains a critical priority.
In this webinar, Prof. Peter Ebeling discusses the evolving landscape of osteoporosis management, emphasising the growing importance of risk stratification to identify and treat high-risk fracture patients. He will also explore strategies for recognising patients at very high fracture risk within FLS settings and the role of timely, targeted treatment interventions in reducing the risk of subsequent fractures. Participants will gain insights into optimising patient pathways and strengthening secondary fracture prevention through effective risk assessment and evidence-based management approaches. KEY LEARNING OBJECTIVES OF THIS WEBINAR INCLUDE:• Identifying patients at very high fracture risk using evidence-based risk stratification approaches within FLS settings.
• Optimising treatment strategies through timely, targeted interventions tailored to patients’ fracture risk and clinical needs.
• Strengthening secondary fracture prevention by optimising FLS pathways and addressing missed opportunities to prevent subsequent fractures. | | |
|
| |
 |
Prof. Peter Ebeling, AO | Professor Peter Ebeling AO FAHMS is a Clinician Scientist with the Department of Medicine, Temerty Faculty of Medicine, University of Toronto, based in the Division of Endocrinology at St. Michael's Hospital and in its associated Li Ka Shing Knowledge Institute. Previously, he served as Head of the Department of Medicine and the School of Clinical Sciences in the Faculty of Medicine, Nursing and Health Sciences at Monash University in Melbourne, Australia. Professor Ebeling has held numerous international leadership roles, including being the Director of the Australian Institute of Musculoskeletal Science. He is Chair of Healthy Bones Australia; Board Member, International Osteoporosis Foundation; Past-President, American Society of Bone and Mineral Research, the first to be elected outside of North America; Past-President, Endocrine Society of Australia; Past-President of the Australian and New Zealand Bone and Mineral Society (ANZBMS). He was on the NHMRC Academy (2009-2014) and served on the NHMRC Research Committee (2015-2018). He has over 635 peer-reviewed publications, including in The New England Journal of Medicine, Lancet, Science and JBMR. He also teaches and mentors medical students and supervises a number of research higher degree students and advanced physician trainees in endocrinology. |
|
|
| |
|
| |
Be sure to attend the live webinar!Please note that following the webinar, the webinar recording will only be available for a period of 3 days, for registrants only. |
|
